When combined with genetic risk factors, SCD subjects who are ApoE ɛ4 carriers showed more severe atrophy in the left hippocampus [84] and an additive reduction in the right cortical surface area [85] than noncarriers; this outcome is consistent with the results from longitudinal studies [86]. This evidence concerns the gene APOE and Schnyder corneal dystrophy.